A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market

A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market

A New Standard of Care May be on the Horizon


RELEASE DATE
19-Sep-2014
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
NE07-01-00-00-00
SKU
LS00127-NA-MR_16968
Yes
SHARE

$5,000.00

Special Price $3,750.00 save 25 %

In stock
SKU
LS00127-NA-MR_16968

A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market
Published on: 19-Sep-2014 | SKU: LS00127-NA-MR_16968

Need more details?

$5,000.00

$3,750.00 save 25 %

DownloadLink
Need more details?

The standard of care, microfracture, does not fulfill long-term needs for patients with chondral defects. In addition, current alternative treatment options are plagued by multiple challenges and limitations. This research service focuses on medicine in the knee cartilage repair market, providing a detailed overview of 9 key products. A product and pipeline assessment is provided for marketed and investigational autologous cell-based therapy, allogenic cell-based therapy, and non-cellular products in the global, US, and European markets. Product profiles are included for companies that are currently or imminently marketing cell-based regenerative therapies and conducting clinical trials in the United States and Europe.

Key Findings

Key Findings (continued)

The Ideal Knee Chondral Defect Repair Solution

Key Companies to Watch

Other Companies to Watch

Market Definitions

Market Opportunity

Market Overview

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Current Cartilage Treatment Options

Significant Unmet Need Continues to Exist for Patients with Grades 3 and 4 Knee Chondral Defects

Technology Improvement Increases Product Utility

Market Drivers and Restraints

Recent Market Developments

Recent Market Developments (continued)

Knee Cartilage Repair Market—Competitive Landscape of Key Products

Knee Cartilage Repair Market—Competitive Landscape of Key Products (continued)

Differentiators for Key Marketed and Pipeline Products

Differentiators for Key Marketed and Pipeline Products (continued)

Differentiators for Key Marketed and Pipeline Products (continued)

Competitive Landscape—Pivotal Phase 3 Trials for Key Products

Competitive Landscape—Post-marketed Trials for Key Products

Global Estimated Approval Timelines for Key Products

Regulatory Pathway for Key Products

Knee Cartilage Repair Market—US Competitive Landscape of all Marketed and Pipeline Products

Marketed Product Analysis of Key Products—US

Pipeline Analysis of Key Products—US

US Competitive Landscape—Pivotal Phase 3 Trials

US Pivotal Phase 3 Trial Details

US Competitive Landscape—Post-marketed Trials

Knee Cartilage Repair Market—Europe Competitive Landscape of all Marketed Products

Knee Cartilage Repair Market—Europe Competitive Landscape of all Pipeline Products

Key Marketed Product Analysis—Europe

Key Marketed Product Analysis—Europe (continued)

Key Product Pipeline Analysis—Europe

Europe Competitive Landscape—Pivotal Phase 3 Trials

Europe Pivotal Phase 3 Trials

Europe Pivotal Phase 3 Trials (continued)

Europe Estimated Approval Timelines

NeoCart—Timelines for Focal Cartilage Defects

NeoCart—Clinical Trial Design Approach and Key Published Data

Product Dashboard—NeoCart

NovoCart 3D—US Timelines for Focal Cartilage Defects

NovoCart 3D—Europe Timelines for Focal Cartilage Defects

NovoCart 3D—Clinical Trial Design Approach and Key Published Data

NovoCart 3D—Clinical Trial Design Approach and Key Published Data (continued)

Product Dashboard—NovoCart 3D

RevaFlex—Timelines for Focal Cartilage Defects

RevaFlex—Clinical Trial Design Approach and Key Published Data

Product Dashboard—RevaFlex

Carticel—Clinical Trial Design Approach and Key Published Data

Carticel—Clinical Trial Design Approach and Key Published Data (continued)

Product Dashboard—Carticel

MACI—Clinical Trial Design Approach and Key Published Data

MACI—Clinical Trial Design Approach and Key Published Data (continued)

Product Dashboard—MACI

ChondroCelect—Clinical Trial Design Approach and Key Published Data

ChondroCelect—Clinical Trial Design Approach and Key Published Data (continued)

Product Dashboard—ChondroCelect

DeNovo NT—Clinical Trial Design Approach and Key Published Data

DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)

DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)

Product Dashboard—DeNovo NT

Product Dashboard—Cartiform

Product Dashboard—BioCartilage

Product Dashboard—Cartistem

Key Opinion Leader (KOL) Insights

Key Opinion Leader (KOL) Insights (continued)

Conclusions

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related industry research

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

06 Aug 2026   |   Global   |   Market Research

Machine Tools Sector, Global, 2023–2030

This study provides an in-depth understanding of the machine tools industry. It discusses the key trends and challenges faced by machine tool manufacturers, in addition to providing forecasts until 2030. The study provides a region-wise breakdown with discussions on key industries. Machine tool manu...

06 Aug 2026   |   Global   |   Market Research

Top Trends Driving the Automotive Market, Global, 2026

Global light vehicle demand remained resilient in 2025, supported by the recovery of major automotive markets, strong APAC momentum, and the continued consumer shift toward electrified and utility-focused vehicles. This report evaluates how the global automotive industry is entering 2026 amid geopol...

05 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Shop Floor-Centric Augmented Connected Worker Platforms, 2026

Manufacturers are confronting a skilled labor shortage. As they try to find a solution, augmented connected worker (ACW) platforms can become a key ally in training the new workforce and strengthening employee retention through comprehensive upskilling capabilities, skills management tools, and assi...

05 Aug 2026   |   Global   |   Market Research

Material Trends and Dynamics in Battery Recycling, 2025–2032

Frost & Sullivan analyzes the global battery recycling market, focusing on the evolving lithium-ion battery (LIB) ecosystem.

The study explores the trends and dynamics shaping the battery recycling value chain, from battery production and usage to collection, pre-processing, material recovery...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The standard of care, microfracture, does not fulfill long-term needs for patients with chondral defects. In addition, current alternative treatment options are plagued by multiple challenges and limitations. This research service focuses on medicine in the knee cartilage repair market, providing a detailed overview of 9 key products. A product and pipeline assessment is provided for marketed and investigational autologous cell-based therapy, allogenic cell-based therapy, and non-cellular products in the global, US, and European markets. Product profiles are included for companies that are currently or imminently marketing cell-based regenerative therapies and conducting clinical trials in the United States and Europe.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Jennifer Lazar
WIP Number NE07-01-00-00-00
Is Prebook No